tiprankstipranks
Roche Holding (GB:0TDF)
LSE:0TDF
UK Market
0TDF
Roche Holding
RESEARCH TOOLSreports

Roche Holding (0TDF) Share Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

0TDF Analyst Ratings

Moderate Buy
1Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
Based on 1 analysts giving stock ratings to
Roche
Holding
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0TDF Stock 12 Month Forecast

Average Price Target

$63.00
▲(16.02% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Roche Holding in the last 3 months. The average price target is $63.00 with a high forecast of $63.00 and a low forecast of $63.00. The average price target represents a 16.02% change from the last price of $54.30.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"38":"$38","51":"$51","64":"$64","44.5":"$44.5","57.5":"$57.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":63,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$63.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":63,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$63.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":63,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$63.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[38,44.5,51,57.5,64],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.632,55.2756923076923,55.919384615384615,56.56307692307692,57.20676923076923,57.85046153846154,58.49415384615384,59.137846153846155,59.78153846153846,60.425230769230765,61.06892307692308,61.71261538461538,62.356307692307695,{"y":63,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.632,55.2756923076923,55.919384615384615,56.56307692307692,57.20676923076923,57.85046153846154,58.49415384615384,59.137846153846155,59.78153846153846,60.425230769230765,61.06892307692308,61.71261538461538,62.356307692307695,{"y":63,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.632,55.2756923076923,55.919384615384615,56.56307692307692,57.20676923076923,57.85046153846154,58.49415384615384,59.137846153846155,59.78153846153846,60.425230769230765,61.06892307692308,61.71261538461538,62.356307692307695,{"y":63,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":39.081,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":39.939,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":43.418,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":39.541,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.219,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.79,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.604,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.009,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.192,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.091,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.397,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.844,"date":1782864000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":54.632,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$63.00Average Price Target$63.00Lowest Price Target$63.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on GB:0TDF
Sarita Kapila
Morgan Stanley
Morgan Stanley
$295→$63
Buy
16.02%
Upside
Upgraded
08/07/26
Positive Report for Roche Holding (RHHBY) from Morgan Stanley
Berenberg Bank Analyst forecast on GB:0TDF
Unknown Analyst
Berenberg Bank
Not Ranked
Berenberg Bank
$55
Hold
1.29%
Upside
Reiterated
05/08/26
Berenberg Bank Remains a Hold on Roche Holding (RHHBY)
TD Cowen Analyst forecast on GB:0TDF
Steve Scala
TD Cowen
TD Cowen
$67
Hold
23.39%
Upside
Reiterated
04/23/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Roche Holding (Other OTC: RHHBY), Praxis Precision Medicines (NASDAQ: PRAX) and SAB Biotherapeutics (NASDAQ: SABS)
Argus Research Analyst forecast on GB:0TDF
Jasper Hellweg
Argus Research
Argus Research
$55
Buy
1.29%
Upside
Upgraded
04/06/26
Roche upgraded to Buy from Hold at ArgusRoche upgraded to Buy from Hold at Argus
Exane BNP Paribas Analyst forecast on GB:0TDF
Peter Verdult
Exane BNP Paribas
Exane BNP Paribas
$50
Hold
-7.92%
Downside
Downgraded
03/17/26
Roche downgraded to Neutral from Outperform at BNP ParibasRoche downgraded to Neutral from Outperform at BNP Paribas
Goldman Sachs Analyst forecast on GB:0TDF
James Quigley
Goldman Sachs
Goldman Sachs
―
Hold
―
Upgraded
01/15/26
Roche upgraded to Neutral from Sell at Goldman SachsRoche upgraded to Neutral from Sell at Goldman Sachs
Barclays Analyst forecast on GB:0TDF
Emily Field
Barclays
Barclays
―
Buy
―
Upgraded
01/06/26
Roche upgraded to Overweight from Equal Weight at BarclaysRoche upgraded to Overweight from Equal Weight at Barclays
HSBC Analyst forecast on GB:0TDF
Rajesh Kumar
HSBC
HSBC
$50→$57
Buy
4.97%
Upside
Reiterated
12/10/25
Roche price target raised to $57 from $50 at HSBCRoche price target raised to $57 from $50 at HSBC
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on GB:0TDF
Sarita Kapila
Morgan Stanley
Morgan Stanley
$295→$63
Buy
16.02%
Upside
Upgraded
08/07/26
Positive Report for Roche Holding (RHHBY) from Morgan Stanley
Berenberg Bank Analyst forecast on GB:0TDF
Unknown Analyst
Berenberg Bank
Not Ranked
Berenberg Bank
$55
Hold
1.29%
Upside
Reiterated
05/08/26
Berenberg Bank Remains a Hold on Roche Holding (RHHBY)
TD Cowen Analyst forecast on GB:0TDF
Steve Scala
TD Cowen
TD Cowen
$67
Hold
23.39%
Upside
Reiterated
04/23/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Roche Holding (Other OTC: RHHBY), Praxis Precision Medicines (NASDAQ: PRAX) and SAB Biotherapeutics (NASDAQ: SABS)
Argus Research Analyst forecast on GB:0TDF
Jasper Hellweg
Argus Research
Argus Research
$55
Buy
1.29%
Upside
Upgraded
04/06/26
Roche upgraded to Buy from Hold at ArgusRoche upgraded to Buy from Hold at Argus
Exane BNP Paribas Analyst forecast on GB:0TDF
Peter Verdult
Exane BNP Paribas
Exane BNP Paribas
$50
Hold
-7.92%
Downside
Downgraded
03/17/26
Roche downgraded to Neutral from Outperform at BNP ParibasRoche downgraded to Neutral from Outperform at BNP Paribas
Goldman Sachs Analyst forecast on GB:0TDF
James Quigley
Goldman Sachs
Goldman Sachs
―
Hold
―
Upgraded
01/15/26
Roche upgraded to Neutral from Sell at Goldman SachsRoche upgraded to Neutral from Sell at Goldman Sachs
Barclays Analyst forecast on GB:0TDF
Emily Field
Barclays
Barclays
―
Buy
―
Upgraded
01/06/26
Roche upgraded to Overweight from Equal Weight at BarclaysRoche upgraded to Overweight from Equal Weight at Barclays
HSBC Analyst forecast on GB:0TDF
Rajesh Kumar
HSBC
HSBC
$50→$57
Buy
4.97%
Upside
Reiterated
12/10/25
Roche price target raised to $57 from $50 at HSBCRoche price target raised to $57 from $50 at HSBC
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ODTXOdyssey Therapeutics, Inc.
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
GPCRStructure Therapeutics, Inc. Sponsored ADR
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Roche Holding

3 Months
OpenAI Drug Manufacturers - GeneralTipRanks - OpenAI
Success Rate
2/2 ratings generated profit
100%
Average Return
+20.20%
Copying OpenAI Drug Manufacturers - General's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +20.20% per trade.
1 Year
Rajesh KumarHSBC
Success Rate
2/2 ratings generated profit
100%
Average Return
+27.05%
Copying Rajesh Kumar's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +27.05% per trade.
2 Years
Rajesh KumarHSBC
Success Rate
2/2 ratings generated profit
100%
Average Return
+27.05%
Copying Rajesh Kumar's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +27.05% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0TDF Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
2
2
2
0
1
Hold
5
4
2
1
0
Sell
1
1
1
0
0
Strong Sell
0
0
0
0
0
total
8
7
5
1
1
In the current month, 0TDF has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0TDF average Analyst price target in the past 3 months is 63.00.
Each month's total comprises the sum of three months' worth of ratings.

0TDF Financial Forecast

0TDF Earnings Forecast

Next quarter’s earnings estimate for 0TDF is $1.49 with a range of $1.44 to $1.52. The previous quarter’s EPS was $1.66. 0TDF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0TDF has Performed in-line its overall industry.
Next quarter’s earnings estimate for 0TDF is $1.49 with a range of $1.44 to $1.52. The previous quarter’s EPS was $1.66. 0TDF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0TDF has Performed in-line its overall industry.

0TDF Sales Forecast

Next quarter’s sales forecast for 0TDF is $39.79B with a range of $38.97B to $41.03B. The previous quarter’s sales results were $38.59B. 0TDF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0TDF has Performed in-line its overall industry.
Next quarter’s sales forecast for 0TDF is $39.79B with a range of $38.97B to $41.03B. The previous quarter’s sales results were $38.59B. 0TDF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0TDF has Performed in-line its overall industry.

0TDF Stock Forecast FAQ

What is GB:0TDF’s average 12-month price target, according to analysts?
Based on analyst ratings, Roche Holding’s 12-month average price target is 63.00.
    What is GB:0TDF’s upside potential, based on the analysts’ average price target?
    Roche Holding has 16.02% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Roche Holding a Buy, Sell or Hold?
          Roche Holding has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Roche Holding’s share price target?
            The average share price target for Roche Holding is 63.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $63.00 ,and the lowest forecast is $63.00. The average share price target represents 16.02% Increase from the current price of $54.3.
              What do analysts say about Roche Holding?
              Roche Holding’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
                How can I buy shares of Roche Holding?
                To buy shares of GB:0TDF, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.